The Department of Health and Human Services, through the National Cancer Institute (NCI), has released a Funding Opportunity Announcement (FOA) inviting grant applications for investigator-initiated Program Project Applications (P01) for 2023-2025. This initiative supports integrated cancer research programs focusing on diverse areas such as cancer biology, prevention, diagnosis, treatment, and control. Each application must include at least three interrelated research projects alongside an Administrative Core, all centered around a unified scientific goal. Key dates include the earliest submission date of April 25, 2023, with subsequent deadlines throughout 2024 and 2025. Eligible applicants range from higher education institutions to non-profits and government entities, with a noted encouragement for underrepresented groups in research. The funding is anticipated to vary based on NIH appropriations, with project periods extending up to five years. The FOA emphasizes adherence to application guidelines outlined in the SF424 Application Guide and stresses the importance of a Data Management and Sharing Plan. Review criteria include scientific significance, innovation, approach, and the qualifications of investigators. This structured initiative aims to accelerate collaborative cancer research, enhancing the understanding and treatment of cancer through coordinated efforts among multiple disciplines.